Patrik Brundin joined Van Andel Institute in 2012, where he is Deputy Chief Scientific Officer and directs the Center for Parkinson's Disease. He earned his Ph.D. in 1988 and M.D. in 1992, both from Lund University, Sweden and is highly cited in neuroscience with more than 400 publications on Parkinson's disease and related topics. His research focuses on pathogenic mechanisms of Parkinson's and development of therapies that slow or stop disease progression or that repair damaged brain circuits. He is a member of the World Parkinson Coalition Board of Directors and The Michael J. Fox Foundation for Parkinson's Research Executive Scientific Advisory Board. He also serves as co-editor-in-chief of the Journal of Parkinson's Disease and chair of the Linked Clinical Trials scientific committee.